Professor Tony Cunningham’s research focus is the immunology and pathogenesis of virus infections in humans, and the development of new vaccine candidates and therapeutic strategies. His work on herpes simplex immunology led directly to the only (partly) successful vaccine candidate for genital and neonatal herpes. He remains at the forefront of this field. He then developed the first system to study the mechanism of transport of HSV in human nerves, defining a potential new therapeutic strategy. He also defined the mechanisms of HIV transport through the first cells infected by HIV, to target T cells, and how the virus subverts their function.